Frontage Labs Plans Expansion of CMC Facility - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Frontage Labs Plans Expansion of CMC Facility


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 7

Frontage Labs reported plans to expand its chemistry, manufacturing, and controls (CMC) facility in Exton, PA. The expansion includes increased incremental capacity to existing services and will also provide Frontage with additional room for future growth.

The renovation plan involves two phases. Initial improvements, which include two analytical laboratories and 8000 square feet of office space, will begin in mid-2014, with completion scheduled for the end of September. The second phase, which includes additional clinical trial manufacturing space for solid, semi-solid, and sterile pharmaceutical products and packaging, labeling, and distribution functions, will be implemented at the beginning of 2015. Following the completion of this expansion in mid-2015, Frontage expects to increase its CMC workforce and capacity by more than 50%.

Source:Frontage Labs

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
13%
Provide treatment for patients globally.
11%
All of the above.
39%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here